Month: December 2020

In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stocks to buy, but with markets at all-time highs, many of them have gotten stretched when it comes to valuation. With concerns 2020’s overvalued stock market will head lower in 2021, it may not be best
0 Comments
In this video, we’re going to talk about the difference between buying a call and selling a put. You’ll understand this quickly because we will go into details that will be a real eye-opener for you. You’re going to see in which scenarios you’re going to make money. Also, I’ll show you when you need
0 Comments
Throughout the year, AMC Entertainment Holdings (NYSE:AMC) has traded within a wide range. Before the novel coronavirus shut down movie theatres, AMC stock struggled because the market was concerned about its enormous debt. But as U.S. states lifted their lockdowns during the summer, speculators gambled that movie attendance would rebound, causing the shares to climb.
0 Comments
The future of healthcare will look so different that you may feel like you stepped into a new universe. From telemedicine to precision medicine to genetic therapy, the global healthcare industry is about to shake up like never before. Source: by InvestorPlace That said, one of the key pillars to getting there is genetic testing,
0 Comments
What Is the FDIC? The Federal Deposit Insurance Corporation (FDIC) was created at the height of the Great Depression, following the closure of 4,000 banks in the first few months of 1933 and the loss of $1.3 billion in deposits. President Franklin Roosevelt signed the Banking Act of 1933 on June 16 of that year,
0 Comments
Due to a combination of several factors, Pfizer’s (NYSE:PFE) vaccine for the novel coronavirus, by itself, may not ever move the needle a great deal for PFE stock. Source: Manuel Esteban / Shutterstock.com On the other hand, over the long-term, Pfizer’s collaboration with German vaccine developer BioNTech (NASDAQ:BNTX), which developed the mRNA-based coronavirus vaccine with
0 Comments